Surf Theraphy Rx is categorized under Rehabilitation Center, Outpatient Treatment in Van Nuys, CA and active since 2013.
Surf Theraphy Rx was established in 2013, and today employs 1 to 4, earning Unknown per year. This is a Rehabilitation Center, Outpatient Treatment business, which does work in the B2C market, and is classified as a Rehabilitation Center, Outpatient Treatment, under code number 621498 by the NAICS.
If you are seeking more information, feel free to contact Dorian Paskowitz at the company’s single location by writing to 7038 De Celis Place Unit 4, Van Nuys, California CA 91406 or by phoning (818) 671-7829. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Surf Theraphy Rx |
| Contact Person: | Dorian Paskowitz |
| Address: | 7038 De Celis Place Unit 4, Van Nuys, California 91406 |
| Phone Number: | (818) 671-7829 |
| Annual Revenue (USD): | Unknown |
| Founded: | 2013 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Rehabilitation Center, Outpatient Treatment |
| SIC Code: | 8093 |
| NAICS Code: | 621498 |
| Share This Business: |
Surf Theraphy Rx was started in 2013 to provide professional Rehabilitation Center, Outpatient Treatment under the SIC code 8093 and NAICS code 621498. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Dorian Paskowitz for inquiries that concern Surf Theraphy Rx by calling the company number (818) 671-7829, as your correspondence is most welcome. Additionally, the physical location of the single location of Surf Theraphy Rx can be found at the coordinates 34.198747,-118.494421 as well as the street address 7038 De Celis Place Unit 4 in Van Nuys, California 91406.
For its online presence, you may visit Surf Theraphy Rx’s website at and engage with its social media outlets through on Twitter and on Facebook.